These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30635080)

  • 1. Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I.
    Fernández-Higuero JÁ; Betancor-Fernández I; Mesa-Torres N; Muga A; Salido E; Pey AL
    Adv Protein Chem Struct Biol; 2019; 114():119-152. PubMed ID: 30635080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I.
    Mesa-Torres N; Fabelo-Rosa I; Riverol D; Yunta C; Albert A; Salido E; Pey AL
    PLoS One; 2013; 8(8):e71963. PubMed ID: 24205397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants.
    Vankova P; Pacheco-Garcia JL; Loginov DS; Gómez-Mulas A; Kádek A; Martín-Garcia JM; Salido E; Man P; Pey AL
    FEBS Lett; 2024 Feb; 598(4):485-499. PubMed ID: 38243391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Cellini B
    Curr Drug Targets; 2016; 17(13):1482-91. PubMed ID: 26931357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.
    Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ
    J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
    Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ
    J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition of PTS-1 cargo proteins by Pex5p: implications for protein mistargeting in primary hyperoxaluria.
    Mesa-Torres N; Tomic N; Albert A; Salido E; Pey AL
    Biomolecules; 2015 Feb; 5(1):121-41. PubMed ID: 25689234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
    Leiper JM; Oatey PB; Danpure CJ
    J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
    Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I.
    Roncador A; Oppici E; Talelli M; Pariente AN; Donini M; Dusi S; Voltattorni CB; Vicent MJ; Cellini B
    Nanomedicine; 2017 Apr; 13(3):897-907. PubMed ID: 27993722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
    Danpure CJ; Jennings PR
    Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.
    Danpure CJ; Jennings PR; Fryer P; Purdue PE; Allsop J
    J Inherit Metab Dis; 1994; 17(4):487-99. PubMed ID: 7967498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1.
    Grottelli S; Annunziato G; Pampalone G; Pieroni M; Dindo M; Ferlenghi F; Costantino G; Cellini B
    J Med Chem; 2022 Jul; 65(14):9718-9734. PubMed ID: 35830169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.
    Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y
    J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.